Dassault Systèmes SE (0HB4)
London Exchange · UK · prices in EUR · close of 15 Oct 2026
Key indicators
| Last close | EUR 23.06 |
|---|---|
| 52-week range | 15.84 – 40.88 |
| Return, 1 month / 3 months | +9.0% / +26.8% |
| Return, 1 year / 3 years | −19.1% / −34.4% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 130.5% |
| Worst drawdown (1 year) | -59.1% |
| Average daily value traded | 7.16M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dassault Systèmes is a French software company that provides three-dimensional design, simulation and product lifecycle management tools. Its software helps manufacturers and engineers model products, test how designs behave and manage information across the development process. Customers come from industries such as aerospace, automotive, industrial equipment and life sciences, and the company serves them around the world from its base in France. It also offers consulting and support services alongside its software platforms.
On this site Dassault Systèmes SE appears as a stock on the London Exchange (UK), code 0HB4, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dassault Systèmes SE (0HB4) trades on the London Exchange in UK. It last closed at EUR 23.06 on 15 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,252 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.1% and over the last three months it rose 26.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 15.3% | ||
| From 52-week high | -43.6% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 26.8% | ||
| 6-month return | 29.8% | ||
| 12-month return, skipping the last month | -25.8% | ||
| Stability (higher is calmer) | 8 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 130.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.1% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 7.16M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +9.0% |
| 3 months | +26.8% |
| 6 months | +29.8% |
| 1 year | −19.1% |
| 3 years | −34.4% |
| 5 years | −47.9% |
Signals
| 50-day / 200-day average | 21.53 / 20.00 |
|---|---|
| Golden / death cross (60 days) | Golden, 28 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | EUR 0.2700 |
| 23 May 2025 | EUR 0.2600 |
| 24 May 2024 | EUR 0.2300 |
| 26 May 2023 | EUR 0.2100 |
| 23 May 2022 | EUR 0.1700 |
| 28 May 2021 | EUR 0.5600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.